Hepatho
Hepatho, licence 80010675: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Laboratoire Léo Désilets M.H.
- NPN or DIN-HM
- 80010675
- Status
- Active licence
- Licence date
- 5 June 2009
- Revision date
- 2 June 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Peumus boldus Source : Feuille(s) | 110.0 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Pour favoriser la santé du foie.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Ne pas utiliser en cas de grossesse ou d'allaitement.
- Contre-indications
Consulter un praticien de soins de santé si l'utilisation se prolonge au-delà de 4 semaines. Consulter un praticien de soins de santé si les symptômes persistent ou s'aggravent. Consulter un praticien de soins de santé avant d'en faire l'usage si vous souffrez d'une maladie du foie, si vous souffrez troubles de reins, si vous souffrez de diabète ou vous prenez des médicaments contre le diabète. Consulter un praticien de santé si vous prenez des médicaments psychoactifs. Ne pas utiliser en cas d'allergie à la famille des astéracées ou composées (marguerite jaune).
Source
Official Health Canada record, licence 80010675
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.